US Broker Ratings

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 65% Potential Upside in the Booming Biotech Sector

Investors with an eye on the healthcare sector may find Immunovant, Inc. (NASDAQ: IMVT) an intriguing opportunity. This clinical-stage biotechnology firm, based in New York and a subsidiary of Roivant..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 71.91% Potential Upside

UFP Technologies, Inc. (NASDAQ: UFPT) stands out in the healthcare sector, particularly within the medical devices industry, as it continues to pique investor interest with its innovative solutions and promising..

SS Innovations International (SSII) Stock Analysis: Revenue Soars with Innovative Surgical Solutions

SS Innovations International Inc. (SSII), trading on the Indian market, is carving its niche in the healthcare sector with a market capitalization of approximately $980.64 million. As a commercial-stage surgical..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 100.72% Upside Potential in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, has been drawing attention with its noteworthy potential upside of 100.72%. As a medical technology company, Enovis focuses on..

CRISPR Therapeutics AG (CRSP) Stock Analysis: A Deep Dive into its 79% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering company in the gene-editing landscape, presents a compelling investment case with a potential upside of 79.09%, according to the latest analyst ratings. This..

Metsera, Inc. (MTSR)

⚠️ No article content returned.

..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Unpacking the 37.86% Potential Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a biopharmaceutical company headquartered in Boulder, Colorado, has captured investor attention with a compelling potential upside of 37.86%. This promising figure, combined with a robust..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a Potential 167.64% Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is a biopharmaceutical endeavor that stands at the forefront of developing treatments for rare and ultra-rare genetic diseases. This California-based company, with a market capitalization..

GeneDx Holdings Corp. (WGS) Investor Outlook: A 117% Potential Upside Sparks Interest

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is capturing investor attention with its remarkable potential upside. With a..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a Potential 51% Upside

Bausch Health Companies Inc. (NYSE: BHC), a diversified healthcare entity, has drawn attention from investors with its impressive potential upside of 51.26%, as indicated by the current analyst target price..

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a 154% Potential Upside in Biotech

Biohaven Ltd. (BHVN), a prominent player in the biotechnology sector, has been capturing investor attention due to its promising pipeline of therapeutics and an impressive potential upside. Headquartered in New..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech with 14% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the biotechnology sector, not only for its innovative pipeline but also for its promising potential upside. With a market capitalization of $6.29..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 98% Upside Potential in the Biotech Sector

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering entity in the biotechnology sector, has emerged as a promising contender in the healthcare industry. With a market capitalization of $2.56 billion, this..

Warby Parker Inc. (WRBY) Stock Analysis: Strong Buy Ratings Signal Potential 20% Upside

Warby Parker Inc. (NYSE: WRBY), a prominent player in the eyewear industry, has captured the attention of investors with its innovative business model and robust growth prospects. At the forefront..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Analyzing a Promising 117% Upside Potential

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out in the healthcare sector, particularly within the drug manufacturing space, for its robust pipeline and substantial growth potential. With a market capitalization of..

NewAmsterdam Pharma (NAMS) Stock Analysis: Potential 63.41% Upside with Promising Biotech Innovations

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is making waves in the biotechnology sector with its innovative approach to treating cardiometabolic diseases. With a market capitalization of $3.45 billion, this Netherlands-based..

Twist Bioscience Corporation (TWST) Stock Analysis: Insights into a 12% Potential Upside

Twist Bioscience Corporation (NASDAQ: TWST), a dynamic player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its promising growth trajectory and innovative..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating Market Challenges with 23.7% Revenue Growth

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, is making waves with its commitment to developing innovative treatments for rare diseases. Despite operating in a challenging..

ImmunityBio, Inc. (IBRX) Stock Analysis: A Biotech with 57% Upside Potential and Rapid Revenue Growth

ImmunityBio, Inc. (NASDAQ: IBRX) has captured investor attention with its remarkable positioning in the biotechnology sector. The San Diego-based company focuses on innovative immunotherapies aimed at activating the immune system..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 70% Potential Upside in Biotech Investment

Vericel Corporation (NASDAQ: VCEL), a leading player in the healthcare sector, particularly within the biotechnology industry, has been catching the eye of investors with its robust growth metrics and promising..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds